MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image 3E BIOVENTURES CAPITAL
3E BIOVENTURES CAPITAL

3E BIOVENTURES CAPITAL

Summary

3E Bioventures Capital is a healthcare focused fund dedicated to investing in frontier technologies.

Deals Overview

Total Deals3
Valued Deals3
Total Value£ 549 M
Avg. Deal Size£ 183 M

Market Context

Sort

16 Jun 2020|United States|Biotechnology
C4 Therapeutics
Rtw Investments

Target: C4 THERAPEUTICS INC

Bidder: RTW INVESTMENTS

16 Service Providers

5 Target | 11 Bidder

26 Dealmakers

3 Target | 22 Bidder

£ 119 M

Value

23 Nov 2020|United States|Biotechnology
ONCOIMMUNE
Merck & Co

Target: ONCOIMMUNE

Bidder: MERCK & CO

4 Service Providers

3 Target | 1 Bidder

10 Dealmakers

2 Target | 8 Bidder

£ 319 M

Value

03 Feb 2022|United States|Biotechnology
Dewpoint Therapeutics
Softbank Vision Fund 2

Target: DEWPOINT THERAPEUTICS

Bidder: SOFTBANK VISION FUND 2

6 Service Providers

2 Target | 4 Bidder

6 Dealmakers

3 Target | 3 Bidder

£ 110 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite